New pacidamycin antibiotics through precursor-directed biosynthesis

Grüschow, Sabine, Rackham, Emma J., Elkins, Benjamin, Newill, Philip L. A., Hill, Lionel M. and Goss, Rebecca J. M. (2009) New pacidamycin antibiotics through precursor-directed biosynthesis. ChemBioChem, 10 (2). pp. 355-360. ISSN 1439-7633

Full text not available from this repository.


Pacidamycins, mureidomycins and napsamycins are structurally related uridyl peptide antibiotics that inhibit translocase I, an as yet clinically unexploited target. This potentially important bioactivity coupled to the biosynthetically intriguing structure of pacidamycin make this natural product a fascinating subject for study. A precursor-directed biosynthesis approach was employed in order to access new pacidamycin derivatives. Strikingly, the biosynthetic machinery exhibited highly relaxed substrate specificity with the majority of the tryptophan analogues that were administered; this resulted in the production of new pacidamycin derivatives. Remarkably, 2-methyl-, 7-methyl-, 7-chloro- and 7-bromotryptophans produced their corresponding pacidamycin analogues in larger amounts than the natural pacidamycin. Low levels or no incorporation was observed for tryptophans substituted at positions 4, 5 and 6. The ability to generate bromo- and chloropacidamycins opens up the possibility of further functionalising these compounds through chemical cross-coupling in order to access a much larger family of derivatives.

Item Type: Article
Faculty \ School: Faculty of Science > School of Chemistry
Depositing User: Rachel Smith
Date Deposited: 22 Mar 2011 15:53
Last Modified: 15 Jun 2023 14:30
DOI: 10.1002/cbic.200800575

Actions (login required)

View Item View Item